Mindy C DeRouen1,2, Alison J Canchola1,3, Caroline A Thompson4,5,6, Anqi Jin6, Sixiang Nie7, Carmen Wong7, Daphne Lichtensztajn1,3, Laura Allen1, Manali I Patel8, Yihe G Daida7, Harold S Luft6, Salma Shariff-Marco1,2,3, Peggy Reynolds1,2, Heather A Wakelee9, Su-Ying Liang6, Beth E Waitzfelder7, Iona Cheng1,2,3, Scarlett L Gomez1,2,3. 1. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. 2. Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. 3. Greater Bay Area Cancer Registry, University of California San Francisco, CA, USA. 4. San Diego State University School of Public Health, San Diego, CA, USA. 5. University of California San Diego School of Medicine, San Diego, CA, USA. 6. Sutter Health Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA. 7. Kaiser Permanente Hawai'i Center for Integrated Health Care Research, Honolulu, HI, USA. 8. VA Palo Alto Health Care System, Palo Alto, CA, USA. 9. Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Abstract
BACKGROUND: Although lung cancer incidence rates according to smoking status, sex, and detailed race/ethnicity have not been available, it is estimated that more than half of Asian American, Native Hawaiian, and Pacific Islander (AANHPI) females with lung cancer have never smoked. METHODS: We calculated age-adjusted incidence rates for lung cancer according to smoking status and detailed race/ethnicity among females, focusing on AANHPI ethnic groups, and assessed relative incidence across racial/ethnic groups. We used a large-scale dataset that integrates data from electronic health records from 2 large health-care systems-Sutter Health in Northern California and Kaiser Permanente Hawai'i-linked to state cancer registries for incident lung cancer diagnoses between 2000 and 2013. The study population included 1 222 694 females (n = 244 147 AANHPI), 3297 of which were diagnosed with lung cancer (n = 535 AANHPI). RESULTS: Incidence of lung cancer among never-smoking AANHPI as an aggregate group was 17.1 per 100 000 (95% confidence interval [CI] = 14.9 to 19.4) but varied widely across ethnic groups. Never-smoking Chinese American females had the highest rate (22.8 per 100 000, 95% CI = 17.3 to 29.1). Except for Japanese American females, incidence among every never-smoking AANHPI female ethnic group was higher than that of never-smoking non-Hispanic White females, from 66% greater among Native Hawaiian females (incidence rate ratio = 1.66, 95% CI = 1.03 to 2.56) to more than 100% greater among Chinese American females (incidence rate ratio = 2.26, 95% CI = 1.67 to 3.02). CONCLUSIONS: Our study revealed high rates of lung cancer among most never-smoking AANHPI female ethnic groups. Our approach illustrates the use of innovative data integration to dispel the myth that AANHPI females are at overall reduced risk of lung cancer and demonstrates the need to disaggregate this highly diverse population.
BACKGROUND: Although lung cancer incidence rates according to smoking status, sex, and detailed race/ethnicity have not been available, it is estimated that more than half of Asian American, Native Hawaiian, and Pacific Islander (AANHPI) females with lung cancer have never smoked. METHODS: We calculated age-adjusted incidence rates for lung cancer according to smoking status and detailed race/ethnicity among females, focusing on AANHPI ethnic groups, and assessed relative incidence across racial/ethnic groups. We used a large-scale dataset that integrates data from electronic health records from 2 large health-care systems-Sutter Health in Northern California and Kaiser Permanente Hawai'i-linked to state cancer registries for incident lung cancer diagnoses between 2000 and 2013. The study population included 1 222 694 females (n = 244 147 AANHPI), 3297 of which were diagnosed with lung cancer (n = 535 AANHPI). RESULTS: Incidence of lung cancer among never-smoking AANHPI as an aggregate group was 17.1 per 100 000 (95% confidence interval [CI] = 14.9 to 19.4) but varied widely across ethnic groups. Never-smoking Chinese American females had the highest rate (22.8 per 100 000, 95% CI = 17.3 to 29.1). Except for Japanese American females, incidence among every never-smoking AANHPI female ethnic group was higher than that of never-smoking non-Hispanic White females, from 66% greater among Native Hawaiian females (incidence rate ratio = 1.66, 95% CI = 1.03 to 2.56) to more than 100% greater among Chinese American females (incidence rate ratio = 2.26, 95% CI = 1.67 to 3.02). CONCLUSIONS: Our study revealed high rates of lung cancer among most never-smoking AANHPI female ethnic groups. Our approach illustrates the use of innovative data integration to dispel the myth that AANHPI females are at overall reduced risk of lung cancer and demonstrates the need to disaggregate this highly diverse population.
Authors: Beate Pesch; Benjamin Kendzia; Per Gustavsson; Karl-Heinz Jöckel; Georg Johnen; Hermann Pohlabeln; Ann Olsson; Wolfgang Ahrens; Isabelle Mercedes Gross; Irene Brüske; Heinz-Erich Wichmann; Franco Merletti; Lorenzo Richiardi; Lorenzo Simonato; Cristina Fortes; Jack Siemiatycki; Marie-Elise Parent; Dario Consonni; Maria Teresa Landi; Neil Caporaso; David Zaridze; Adrian Cassidy; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Isabelle Stücker; Eleonora Fabianova; Rodica Stanescu Dumitru; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Charles M Rudin; Paul Brennan; Paolo Boffetta; Kurt Straif; Thomas Brüning Journal: Int J Cancer Date: 2011-12-14 Impact factor: 7.396
Authors: Louise A Brinton; Gretchen L Gierach; Abegail Andaya; Yikyung Park; Arthur Schatzkin; Albert R Hollenbeck; Margaret R Spitz Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-04-05 Impact factor: 4.254
Authors: Angela Cecilia Pesatori; Michele Carugno; Dario Consonni; Neil E Caporaso; Sholom Wacholder; Margaret Tucker; Maria Teresa Landi Journal: Int J Cancer Date: 2012-11-26 Impact factor: 7.396
Authors: Iona Cheng; Scarlett L Gomez; Mindy C DeRouen; Caroline A Thompson; Alison J Canchola; Anqi Jin; Sixiang Nie; Carmen Wong; Jennifer Jain; Daphne Y Lichtensztajn; Yuqing Li; Laura Allen; Manali I Patel; Yihe G Daida; Harold S Luft; Salma Shariff-Marco; Peggy Reynolds; Heather A Wakelee; Su-Ying Liang; Beth E Waitzfelder Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-05-17 Impact factor: 4.254
Authors: Ghassan B Hamra; Neela Guha; Aaron Cohen; Francine Laden; Ole Raaschou-Nielsen; Jonathan M Samet; Paolo Vineis; Francesco Forastiere; Paulo Saldiva; Takashi Yorifuji; Dana Loomis Journal: Environ Health Perspect Date: 2014-06-06 Impact factor: 9.031
Authors: Alka M Kanaya; Ann W Hsing; Sela V Panapasa; Namratha R Kandula; Maria Rosario G Araneta; Daichi Shimbo; Paul Wang; Scarlett L Gomez; Jinkook Lee; K M Venkat Narayan; Marjorie K L Mala Mau; Sonali Bose; Martha L Daviglus; Frank B Hu; Nadia Islam; Chandra L Jackson; Merle Kataoka-Yahiro; John S K Kauwe; Simin Liu; Grace X Ma; Tung Nguyen; Latha Palaniappan; V Wendy Setiawan; Chau Trinh-Shevrin; Janice Y Tsoh; Dhananjay Vaidya; Barbara Vickrey; Thomas J Wang; Nathan D Wong; Sean Coady; Yuling Hong Journal: Ann Intern Med Date: 2022-01-04 Impact factor: 51.598
Authors: Moon S Chen; Richard J Lee; Ravi A Madan; Van Ta Park; Susan M Shinagawa; Tracy Sun; Scarlett L Gomez Journal: J Natl Cancer Inst Date: 2022-06-13 Impact factor: 11.816